Common use of Indemnification Provisions Clause in Contracts

Indemnification Provisions. In connection with the engagement of Maxim Group, LLC (“Maxim”) by Pro-Pharmaceuticals, Inc. (the “Company”) pursuant to a placement agreement dated February 12, 2008, between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-PharmaceuticalsProvectus Biopharmaceuticals, Inc. (the “Company”) pursuant to a placement letter agreement dated February 12August 25, 2008, 2016 between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-Pharmaceuticals, Inc. Genetic Technologies Limited (the “Company”) pursuant to a placement letter agreement dated February 12March 6, 20082015, between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-PharmaceuticalsInterpace Diagnostics Group, Inc. (the “Company”) pursuant to a placement letter agreement dated February 12January 20, 2008, 2017 between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-Pharmaceuticals, Inc. Prima BioMed Ltd (the “Company”) pursuant to a placement letter agreement dated February 12March 31, 20082017, between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-PharmaceuticalsStellar Biotechnologies, Inc. (the “Company”) pursuant to a placement letter agreement dated February 12June 27, 20082016, between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-PharmaceuticalsInterpace Diagnostics Group, Inc. (the “Company”) pursuant to a placement letter agreement dated February 12January 3, 2008, 2017 between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-PharmaceuticalsApplied DNA Sciences, Inc. (the “Company”) pursuant to a placement letter agreement dated February 12November 17, 20082015, between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-Pharmaceuticals, Inc. Adamis Pharmaceuticals Corporation. (the “Company”) pursuant to a placement letter agreement dated February 12July 29, 2008, 2016 between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-Pharmaceuticals, Inc. Genetic Technologies Limited (the “Company”) pursuant to a placement letter agreement dated February 12September 9, 20082016, between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

Indemnification Provisions. In connection with the engagement of Maxim Group, Group LLC (“Maxim”) by Pro-PharmaceuticalsSELLAS Life Sciences Group, Inc. (the “Company”) pursuant to a placement letter agreement dated February 12December 11, 20082020, between the Company and Maxim, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows: